A Preexisting Rare
PIK3CA
E545K
Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in
NRAS
Melanoma and Is Dependent on S6K1 Signaling
A Preexisting Rare
PIK3CA
E545K
Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in
NRAS
Melanoma and Is Dependent on S6K1 Signaling
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now